Scientists Identify New Kind of Stem Cell Found in Testes
Scientists at the Stanford School of Medicine and at the University of California San Francisco have succeeded in isolating stem cells from human testes, which bear a striking resemblance to embryonic stem cells.

Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.

"Scrawny" Gene Keeps Stem Cells Healthy
Scientists at the Carnegie Institution have identified a gene, named scrawny, that appears to be a key factor in keeping a variety of stem cells in their undifferentiated state.

Cellartis Deposits Cell Lines with U.S. National Stem Cell Bank; All NIH Human Embryonic Stem Cell Registry Lines Now on Deposit at NSCB
The U.S. National Stem Cell Bank has announced that it has received deposits of two human embryonic stem cell lines from Cellartis AB, a biotechnology company based in Sweden.

International Stem Cell Begins Pre-Clinical Testing of Its Parthenogenetic Stem Cells for Treatment of Retinal Disease
International Stem Cell Corporation has created layered human tissue from its unique parthenogenetic stem cells and transplanted this tissue into animals in pre-clinical trials to establish a potential new treatment for human retinal diseases

BioLife Solutions Completes Safety Studies on HypoThermosol(R) and CryoStor(TM)
BioLife Solutions Inc. recently announced that it has completed an initial series of small animal safety studies at the Seattle-based Fred Hutchinson Cancer Research Center on its bio-preservation media products, HypoThermosol and CryoStor.

Characterization of Human Embryonic Stem Cells with Features of Neoplastic Progression
The researchers in this study characterize two variant hES cell lines that express pluripotency markers at high levels and do not harbor chromosomal abnormalities by standard cytogenetic measures.

Largest Ever Stem Cell 'Dialogue' Provides Insight into Public Attitudes
Results of the largest ever public dialogue on stem cell research in the UK have revealed high levels of public support for stem cell science and technology, from basic research to development of treatments.

DNA Damage-mediated S and G2 Checkpoints in Human Embryonal Carcinoma Cells
The researchers investigate ionizing radiation-mediated cell cycle checkpoints in undifferentiated and retinoic acid-differentiated human embryonal carcinoma cells to study its genomic integrity.

STEMCELL Technologies Launches Direct Distribution to Singapore
STEMCELL Technologies Inc is pleased to announce the opening of a new sales and distribution office in Singapore, effective January 12th, 2009.

Joint Venture between CHA Biotech and Advanced Cell Technology to be called Stem Cell & Regenerative Medicine International
The joint venture between Advanced Cell Technology, Inc. and leading Korean-based biotechnology company CHA Biotech Co, Ltd., announced recently that the company would be named "Stem Cell & Regenerative Medicine International."

The Massachusetts Life Sciences Center to Start Taking Tax Break, Funding Apps on New Year's Day
The Massachusetts Life Sciences Center, which has been tasked with handling the state's $1 billion Life Sciences Initiative, reports it will start taking online applications for the Life Sciences Tax Incentive Program and the Center's new Life Sciences Accelerator investment program on Jan. 1.

Madison Stem Cell Researchers Get $50,000 State Grant
A Madison company that is developing a better way to grow stem cells has received a $50,000 grant from the state, the governor's office confirmed late recently.

California Funds University of California Irvine Stem Cell Sorting, Tracking Research
Two UC Irvine scientists will receive grants totaling nearly $1.6 million to develop and advance stem cell sorting and tracking devices aimed at improving future therapies for people with brain and spinal cord damage, Alzheimer's and Parkinson's diseases, and other disorders.

Life Technologies to Develop Human Stem Cell Models of Neurodegenerative Diseases to Advance Drug Development
Life Technologies Corporation announced it will use human embryonic stem cells to develop new models of Lou Gehrig's disease and other neurodegenerative diseases with a grant it received this week from the California Institute for Regenerative Medicine.

Invitrogen Launches Xenogeneic-Free Media for Human Embryonic Stem Cell Culture
Invitrogen announced recently that it has launched KNOCKOUT(TM) SR XenoFree Media for use in the culture of human embryonic stem cells.

President-Elect Obama's Choices for Key Science Posts Hailed
President-Elect Barack Obama's recent appointment of four scientific luminaries to major posts in his new administration marks an ambitious attempt to improve U.S. science policy and implementation.